Best Evidence for Vitamin K2 and Arteries

If you’ve spent time in health forums, supplement aisles, or wellness podcasts lately, you’ve probably heard about vitamin K2 and its supposed power to strengthen arteries and prevent cardiovascular disease. The claims sound compelling: a single nutrient that activates special proteins in your arteries, prevents calcium buildup, and keeps your heart healthy into old age. But as someone who values evidence-based decision-making, I’ve learned to be skeptical of simple nutritional panaceas. The real story of vitamin K2 and arteries is far more nuanced—and honestly, more interesting—than the marketing suggests.

In this article, I’ll walk you through what the science actually says about vitamin K2 and arterial health, separate legitimate findings from overblown claims, and help you decide whether supplementation makes sense for your situation. We’ll look at the mechanism, review the strongest human studies, examine the limitations of current evidence, and discuss practical ways to get enough K2 from food. By the end, you should have a clear, evidence-based framework for thinking about vitamin K2—one that respects both what we know and what remains uncertain. [1]

Understanding Vitamin K2: How It Works in Your Body

Before we dive into the cardiovascular research, it helps to understand what vitamin K2 actually is and why it might matter for artery health.

Related: evidence-based supplement guide

Vitamin K exists in two main forms: K1 (phylloquinone), found primarily in leafy greens, and K2 (menaquinone), found mainly in fermented foods and animal products. The distinction matters because they have different roles. While K1 is essential for blood clotting, K2 appears to have a wider range of functions, including activation of proteins involved in bone and cardiovascular health. [5]

The mechanism that captured researchers’ attention involves a protein called matrix Gla protein (MGP). This protein lives in the walls of your arteries and, when properly activated by vitamin K2, helps prevent calcium from depositing in arterial tissue. When calcium accumulates in artery walls—a process called vascular calcification—arteries become stiffer and less able to expand and contract normally. This stiffness is a known risk factor for heart disease and stroke. In theory, adequate K2 keeps arteries flexible by preventing this unwanted calcium buildup.

This mechanism is plausible from a biochemical standpoint, which is why researchers have investigated whether vitamin K2 supplementation can improve real-world cardiovascular outcomes. The fact that a biological mechanism exists doesn’t guarantee that a supplement will deliver clinical benefits, though—a point we’ll return to.

What the Human Evidence Actually Shows

The strongest evidence for vitamin K2 and arteries comes from observational studies—large population surveys that track nutrient intake and health outcomes over time. The most frequently cited research is the Rotterdam Study, a long-term Dutch cohort that examined over 4,800 people and found that higher dietary K2 intake was associated with lower cardiovascular mortality (Geleijnse et al., 2004). Specifically, participants in the highest intake group had about a 50% lower risk of heart disease death compared to those in the lowest group.

This finding sounds dramatic, and it’s been cited in countless supplement marketing materials. But here’s the critical limitation: observational studies can show correlation, not causation. People who eat more K2-rich foods like fermented cheese, natto, and grass-fed dairy might also exercise more, eat less processed food, manage stress better, or have higher socioeconomic status—all factors that independently protect heart health. The protective effect we observe might have little to do with K2 itself.

When researchers have conducted randomized controlled trials—the gold standard for establishing cause-and-effect—the picture becomes murkier. A study published in Thrombosis and Haemostasis (Shea et al., 2015) randomized healthy women to either vitamin K2 supplementation or placebo and measured arterial stiffness using gold-standard imaging techniques. The result? No significant difference between groups. Another trial examining K2’s effect on bone health (which might indirectly affect cardiovascular calcification) also failed to show the robust benefits suggested by observational data.

This gap between observational findings and experimental results is frustratingly common in nutrition research. It suggests that while people with high K2 intake do have better cardiovascular health, K2 supplementation alone may not be sufficient to recreate those benefits. The protective pattern we observe in Rotterdam and similar studies likely reflects a constellation of healthy habits rather than a K2-specific effect. [3]

Vascular Calcification: The Strongest (But Still Limited) Evidence

There is one area where the evidence for vitamin K2 and arteries seems slightly stronger: vascular calcification specifically. [2]

A 2016 meta-analysis examining K2’s effect on arterial calcification found that higher K2 intake was associated with reduced arterial calcification in several studies (Cranenburg et al., 2011). This is meaningful because calcified arteries are demonstrably stiffer and carry higher cardiovascular risk. If K2 truly prevents or slows calcium buildup, it could have real clinical value.

However—and this is crucial—most studies examining vascular calcification in K2 research involve people with chronic kidney disease, a population with abnormal calcium-phosphate metabolism. These findings may not apply to healthy, generally well-nourished people. For the general population, we still lack high-quality randomized trials measuring vascular calcification as the primary outcome.

The research on bone health is worth mentioning too. Some evidence suggests K2 contributes to bone density maintenance, and since bone and arterial calcification are sometimes metabolically linked, better bone health might indirectly support artery health. But again, the evidence is more suggestive than conclusive.

The Supplement Hype Versus Dietary Reality

One reason the evidence around vitamin K2 and arteries remains unclear is that most randomized trials have used synthetic K2 supplements in relatively short studies (weeks to months). Real-world cardiovascular benefits from nutrient intake typically manifest over years or decades. It’s plausible that meaningful K2 supplementation requires longer trials than we currently have.

That said, supplement companies have been quick to market K2 products, often emphasizing the observational data while downplaying the absence of robust intervention trials. This is rational from a business perspective—the narrative is compelling, and the supplement is legal and unregulated. But it’s intellectually dishonest to present observational associations as proven causal effects.

More importantly, emphasizing supplements may distract from the proven cardiovascular interventions we often neglect: regular aerobic exercise, adequate sleep, stress management, and a diet rich in whole foods. These have strong evidence behind them and work across multiple mechanisms simultaneously. If you’re considering K2 supplementation, ask yourself: am I already exercising 150 minutes weekly? Sleeping 7-9 hours? Managing stress? Eating mostly whole foods? If not, those foundational factors will return far better health dividends than an expensive supplement.

Getting Vitamin K2 from Food

Rather than supplement, the evidence suggests prioritizing K2-rich foods. If K2 does contribute to artery health, getting it from whole foods comes with additional nutritional benefits and costs minimal money.

The richest sources of K2 are:

• Natto (fermented soybeans): Contains exceptionally high K2 levels, though the acquired taste limits its appeal for many Western consumers
• Hard cheeses (aged cheddar, gouda, brie): Provide K2, calcium, and protein; choose grass-fed varieties when possible
• Grass-fed butter and ghee: Higher in K2 than grain-fed dairy
• Fermented foods (sauerkraut, kimchi, tempeh): Offer K2 plus beneficial bacteria and enzymes
• Egg yolks: Contain moderate K2, plus lutein, choline, and other micronutrients
• Grass-fed meat: Contains K2, though in lower concentrations than fermented foods

A pragmatic approach: aim for one serving of fermented dairy (cheese, yogurt) or a K2-containing food daily. This ensures adequate intake without supplement expense and comes packaged with other beneficial nutrients. For most people eating a reasonably varied diet including some of these foods, K2 deficiency is unlikely.

Who Might Actually Benefit from K2 Supplementation?

While I’ve been cautious about the evidence, certain populations might reasonably consider K2 supplementation:

• Chronic kidney disease patients: These individuals have dysregulated calcium metabolism and are at high cardiovascular risk. The evidence for K2 is somewhat stronger in this group, though even here, human trials are limited.
• Individuals on warfarin or other vitamin K antagonist medications: These people should not supplement K2 without medical oversight, as K2 can interfere with medication efficacy.
• People with documented osteoporosis: Combined with adequate calcium and vitamin D, K2 might support bone health, which indirectly benefits cardiovascular health. But consult your doctor first.
• Those unable to access K2-rich foods: People with severe dietary restrictions might reasonably consider supplementation after consulting a healthcare provider.

For generally healthy people eating a reasonably balanced diet, the evidence does not support supplementation at present. You’re unlikely to see a meaningful difference, and the money spent on supplements could go toward gym membership, better food, or stress-management resources—all of which have stronger evidence behind them. [4]

Conclusion: Making an Evidence-Based Decision

The story of vitamin K2 and arteries illustrates a common pattern in modern nutrition science: promising biochemical mechanisms, suggestive observational data, and hype that outpaces experimental evidence. The mechanism by which K2 activates MGP and prevents vascular calcification is legitimate. Observational studies consistently show that people eating high amounts of K2-rich foods have better cardiovascular outcomes. But randomized controlled trials haven’t yet confirmed that K2 supplementation independently improves heart health in otherwise healthy people.

This doesn’t mean K2 is irrelevant. It likely does contribute to cardiovascular health as part of a nutrient-dense diet. But it’s one factor among dozens. Vitamin K2 and arteries are connected, but that connection is more complex than marketing suggests.

My recommendation: include K2-rich foods in your diet if you enjoy them and have access to them. Eat cheese, fermented foods, and eggs. But don’t rely on supplements as a shortcut to heart health. Instead, prioritize the fundamentals: movement, sleep, stress management, and a diet based on whole foods. These don’t require marketing because they’ve been validated repeatedly across thousands of studies. They’re also more cost-effective and come with zero risk of supplement-drug interactions or false security.

In my experience teaching about evidence-based health, the people who live longest and feel best aren’t those chasing the latest supplement trend. They’re the ones who master the boring basics and maintain them for decades. Vitamin K2 might be a useful supporting player in that story, but it’s not the star.

Last updated: 2026-03-24

References

1. AlBlooshi S (2025). Vitamin K and women’s health: a review. PMC. Link
2. Knapen MHJ et al. (2025). Modulation of Cardiometabolic Risk by Vitamin D and K2. PMC – NIH. Link
3. Gast GCM et al. (2009). A high menaquinone intake reduces the incidence of coronary heart disease. Nutrition, Metabolism and Cardiovascular Diseases. Link
4. Geleijnse JM et al. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Journal of Nutrition. Link
5. Beulens JWJ et al. (2009). High dietary menaquinone intake is associated with reduced coronary calcification. American Journal of Clinical Nutrition. Link
6. Knapen MHJ et al. (2015). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International. Link

Related Reading

• Static Stretching Before Exercise Is Wrong: 2026 Research Explains Why
• Why Your ADHD Meds Stop Working (Fix It Fast)
• How to Teach Problem-Solving Skills [2026]